Finance

Lists
688266:SHA
Suzhou Zelgen Biopharmaceuticals Co Ltd
96,66 CNY
+1,75%
(+1,66) 1D
16 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688266...
Open
96,00 CNY
High
99,98 CNY
Low
96,00 CNY
Mkt. cap
25,59 მლრდ.
Avg. vol.
3,44 მლნ.
Volume
3,02 მლნ.
P/E ratio
46,53
52-wk high
160,00 CNY
52-wk low
75,10 CNY
EPS
2,08 CNY
No. of employees
1 ათ.
Open
96,00 CNY
High
99,98 CNY
Low
96,00 CNY
Mkt. cap
25,59 მლრდ.
Avg. vol.
3,44 მლნ.
Volume
3,02 მლნ.
P/E ratio
46,53
52-wk high
160,00 CNY
52-wk low
75,10 CNY
EPS
2,08 CNY
No. of employees
1 ათ.
News stories
From web sources and news partners
About Suzhou Zelgen Biopharmaceuticals Co Ltd
CEO-
Employees1,06 ათ.
Founded18 მარ. 2009
Headquarters-
Sector-
Websitezelgen.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
217,79 მლნ.
217,04 მლნ.
905,39 მლნ.
299,99 მლნ.
Cost of goods sold
14,54 მლნ.
25,03 მლნ.
27,04 მლნ.
42,87 მლნ.
Cost of revenue
14,54 მლნ.
25,03 მლნ.
27,04 მლნ.
42,87 მლნ.
Research and development expenses
106,28 მლნ.
127,13 მლნ.
92,28 მლნ.
107,25 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
128,56 მლნ.
160,34 მლნ.
151,23 მლნ.
165,74 მლნ.
Operating expense
208,28 მლნ.
315,51 მლნ.
247,77 მლნ.
276,72 მლნ.
Total operating expenses
222,82 მლნ.
340,53 მლნ.
274,81 მლნ.
319,59 მლნ.
Operating income
-5,03 მლნ.
-123,49 მლნ.
630,58 მლნ.
-19,61 მლნ.
Other non operating income
-96,86 ათ.
279,05 ათ.
-6,83 მლნ.
6,52 მლნ.
EBT including unusual items
-20,90 მლნ.
-70,34 მლნ.
631,77 მლნ.
6,88 მლნ.
EBT excluding unusual items
5,30 მლნ.
-118,30 მლნ.
631,73 მლნ.
-15,57 მლნ.
Income tax expense
-877,77 ათ.
-805,16 ათ.
-841,97 ათ.
-522,57 ათ.
Effective tax rate
4,20%
1,14%
-0,13%
-7,60%
Other operating expenses
-26,77 მლნ.
29,52 მლნ.
2,33 მლნ.
2,86 მლნ.
Net income
-20,61 მლნ.
-69,53 მლნ.
632,61 მლნ.
7,40 მლნ.
Net profit margin
-9,46%
-32,03%
69,87%
2,47%
Earnings per share
-
-
-
-
Interest and investment income
13,73 მლნ.
12,79 მლნ.
13,97 მლნ.
14,97 მლნ.
Interest expense
-3,35 მლნ.
-6,97 მლნ.
-6,00 მლნ.
-5,31 მლნ.
Net interest expenses
10,38 მლნ.
5,82 მლნ.
7,98 მლნ.
9,67 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
5,70 მლნ.
-113,00 მლნ.
641,07 მლნ.
-11,51 მლნ.
Gain or loss from assets sale
810,00
-810,00
-
19,99 ათ.
AI content may include mistakes. Learn more
Google აპები